Menu

HomeConferencesCollectionsCalls for PapersMSF Research EthicsAboutMy Saved Content
Logo

Science Portal

  • My Saved Content
  • Browse All
  • Conferences
  • Collections
  • Calls for Papers
  • MSF Research Ethics
  • Clinical Case Reporting
  • About
English
logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.6100.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.6100.produseast1
Conference Material
|Slide Presentation

Operational feasibility and acceptability of the addition of R21 malaria vaccine and intermittent preventive therapy for children to existing malaria control initiatives in Kule, Ethiopia

Girma Y, Lavilla KM, Tassawar A, Siferaw K, Koang D, Tugizimana D, Dirks A, Assefa G, Ayalew M, Loonen JACM, Ariti C, Mapiye G, Mulanda W, de Lima Pereira A, Bestman A, Velivela K, Rao B, Stringer B, Wilson R, Abbara A, Keating P
Download

Countries

Ethiopia

Subject Area

vaccinationpediatricsmalaria

Languages

English
Published Date
22 May 2025
Conference
MSF Scientific Days International 2025
Linked Content
Conference Material
|Abstract
Operational feasibility and acceptability of the addition of R21 malaria vaccine and intermittent preventive therapy for children to existing malaria control initiatives in Kule, Ethiopia
2025 May 22 • MSF Scientific Days International 2025
Similar Content
Abstract
|Abstract
Operational feasibility and acceptability of the addition of R21 malaria vaccine and intermittent preventive therapy for children to existing malaria control initiatives in Kule, Ethiopia
2025 May 22 • MSF Scientific Days International 2025
Loading...
Loading...